Loading...
Loading...
Among the 8 tracked institutional investors we monitor, NBIX (NEUROCRINE BIOSCIENCES INC) is held with a combined value of $4.25B across 31,497,954 shares. The largest holder is BlackRock, Inc. with a position worth $1.76B (0.03% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$4.25B
Total Shares Held
31,497,954
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.76B | 0.03% | +4.3% |
| 2 | VANGUARD GROUP INC | $1.38B | 0.02% | New |
| 3 | STATE STREET CORP | $573.67M | 0.02% | +2.6% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $318.67M | 0.50% | +8.0% |
| 5 | MILLENNIUM MANAGEMENT LLC | $164.34M | 0.07% | +181.7% |
| 6 | FMR LLC | $20.40M | 0.00% | +119.8% |
| 7 | Bridgewater Associates, LP | $19.52M | 0.09% | -1.2% |
| 8 | CITADEL ADVISORS LLC | $11.62M | 0.00% | -24.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of NBIX with a position worth $1.76B, representing 0.03% of their portfolio. In total, 8 institutional investors hold NBIX with a combined value of $4.25B.
In the most recent quarter, 1 fund opened a new position in NBIX. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $4.25B worth of NBIX stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $1.76B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NBIX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their NBIX positions.